-
1
-
-
0022892565
-
Progestational agents in advanced breast cancer: An overview
-
Haller D.G., Glick J.H. Progestational agents in advanced breast cancer An overview . Semin Oncol. 13:1986;2.
-
(1986)
Semin Oncol
, vol.13
, pp. 2
-
-
Haller, D.G.1
Glick, J.H.2
-
2
-
-
0023023018
-
Adjunctive and therapeutic progestins in endometrial cancer
-
Kneale B.L. Adjunctive and therapeutic progestins in endometrial cancer. Clin Obstet Gynaecol. 13:1986;789.
-
(1986)
Clin Obstet Gynaecol
, vol.13
, pp. 789
-
-
Kneale, B.L.1
-
3
-
-
0025302267
-
Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia
-
Loprinzi C.L., Ellison N.M., Schaid D.J., et al. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst. 82:1990;1127.
-
(1990)
J Natl Cancer Inst
, vol.82
, pp. 1127
-
-
Loprinzi, C.L.1
Ellison, N.M.2
Schaid, D.J.3
-
5
-
-
0028577535
-
Megestrol acetate in patients with AIDS and cachexia
-
Oster M.H., Enders S.R., Samuels S.J., et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med. 121:1994;400.
-
(1994)
Ann Intern Med
, vol.121
, pp. 400
-
-
Oster, M.H.1
Enders, S.R.2
Samuels, S.J.3
-
7
-
-
0028077788
-
Randomized trials of megestrol for AIDS-associated anorexia and cachexia
-
Von-Roenn J.H. Randomized trials of megestrol for AIDS-associated anorexia and cachexia. Oncology. 51:(suppl 1):1994;19.
-
(1994)
Oncology
, vol.51
, Issue.SUPPL. 1
, pp. 19
-
-
Von-Roenn, J.H.1
-
8
-
-
0029671042
-
Third generation oral contraceptives and risk of venous thrombotic disorders: An international case control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women
-
Spitzer W.O., Lewis M.A., Heinemann L.A., Thorogood M., MacRae K.D. Third generation oral contraceptives and risk of venous thrombotic disorders: an international case control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. Br Med J. 312:1996;83.
-
(1996)
Br Med J
, vol.312
, pp. 83
-
-
Spitzer, W.O.1
Lewis, M.A.2
Heinemann, L.A.3
Thorogood, M.4
MacRae, K.D.5
-
9
-
-
0029564931
-
Venous thromboembolic disease and combined oral contraceptives: Results of international multicenter case-control study
-
World Health Organization collaborative study of cardiovascular disease and steroid hormone contraception
-
World Health Organization collaborative study of cardiovascular disease and steroid hormone contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicenter case-control study. Lancet 1995;346:1575.
-
(1995)
Lancet
, vol.346
, pp. 1575
-
-
-
10
-
-
13344260005
-
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease
-
World Health Organization collaborative study of cardiovascular disease and steroid hormone contraception
-
World Health Organization collaborative study of cardiovascular disease and steroid hormone contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995;346:1582.
-
(1995)
Lancet
, vol.346
, pp. 1582
-
-
-
11
-
-
0028029477
-
Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation
-
Vandenbroucke J.P., Koster T., Briet E., et al. Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation. Lancet. 344:1994;1453.
-
(1994)
Lancet
, vol.344
, pp. 1453
-
-
Vandenbroucke, J.P.1
Koster, T.2
Briet, E.3
-
12
-
-
0028314865
-
Mutation in blood coagulation factor V associated with resistance to activated protein C
-
Bertina R.M., Koeleman B.P., Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:1994;64.
-
(1994)
Nature
, vol.369
, pp. 64
-
-
Bertina, R.M.1
Koeleman, B.P.2
Koster, T.3
-
13
-
-
0027520285
-
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
-
Koster T., Rosendaal E.R., de Ronde H., et al. Venous thrombosis due to poor anticoagulant response to activated protein C Leiden Thrombophilia Study . Lancet. 342:1993;1503.
-
(1993)
Lancet
, vol.342
, pp. 1503
-
-
Koster, T.1
Rosendaal, E.R.2
De Ronde, H.3
-
14
-
-
0028098210
-
Resistance to activated protein C as a basis for venous thrombosis
-
Svensson P.J., Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. New Engl J Med. 330:1994;517.
-
(1994)
New Engl J Med
, vol.330
, pp. 517
-
-
Svensson, P.J.1
Dahlback, B.2
-
15
-
-
0030934739
-
Oral contraceptives and venous thrombosis: Different sensitivities to activated protein C in women using second- And third-generation oral contraceptives
-
Rosing J., Tans G., Nicolaes G.A.F., et al. Oral contraceptives and venous thrombosis different sensitivities to activated protein C in women using second- and third-generation oral contraceptives . Br J Haematol. 97:1997;233.
-
(1997)
Br J Haematol
, vol.97
, pp. 233
-
-
Rosing, J.1
Tans, G.2
Nicolaes, G.A.F.3
-
16
-
-
0025008994
-
Haemostatic changes during continuous oestradiol-progesterone treatment of postmenopausal women
-
Sporrong T., Mattsson L.-A., Samsioe G., Stigendal L., Hellgren M. Haemostatic changes during continuous oestradiol-progesterone treatment of postmenopausal women. Br J Obstet Gynaecol. 97:1990;939.
-
(1990)
Br J Obstet Gynaecol
, vol.97
, pp. 939
-
-
Sporrong, T.1
Mattsson, L.-A.2
Samsioe, G.3
Stigendal, L.4
Hellgren, M.5
|